What Researchers Did
Researchers presented a single patient's experience with pyoderma gangrenosum, an uncommon inflammatory skin disorder, that was successfully treated using mycophenolate medication and hyperbaric oxygen therapy.
What They Found
The study found that a patient with pyoderma gangrenosum was successfully treated using a combination of mycophenolate and hyperbaric oxygen therapy. This case suggests that a multidisciplinary approach, including HBOT, can be effective for this challenging skin condition, which is known for its unpredictable prognosis and common recurrence.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a case report, this study describes the experience of only one patient, meaning its findings cannot be broadly applied to all individuals with pyoderma gangrenosum.